Checkpoint Inhibitors:Drugs that block immune checkpoint proteins, such as PD-1 and CTLA-4, allowing the immune system to better recognize and attack cancer cells.
Adoptive Cell Transfer: A type of immunotherapy that involves collecting, modifying, and then reintroducing the patient's own immune cells, such as T cells, to enhance their ability to fight cancer.
Monoclonal Antibodies:Antibodies produced in a laboratory that are designed to target specific molecules on the surface of cancer cells, marking them for destruction by the immune system.